Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists
{{output}}
Angelman syndrome (AS), a rare neurogenetic disorder affecting approximately 1 in 15,000 live births, results from loss of functional UBE3A gene expression and manifests with severe developmental delay, intellectual disability, absent speech, ataxia, epilepsy,... ...